mouse monoclonal IgG1; CD130/gp130 Antibody (AN-H2) is an IgG1 κ mouse monoclonal gp130 antibody (also designated IL6ST antibody) that detects gp130 of human origin by IF, IHC(P), FCM and ELISA. CD130/gp130 Antibody (AN-H2) is available as the non-conjugated anti-gp130 antibody form, as well as multiple conjugated forms of anti-gp130 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. IL-6 activates intracellular signaling through binding a receptor consisting of a ligand-binding protein (IL-6R) and a second protein. IL-6 first binds to IL-6R which subsequently associates with a gp130 dimer. The active signaling complex consists of at minimum IL-6, IL-6R and a dimer of two gp130 proteins that are linked by a disulfide bond. A soluble form of IL-6R is generated by proteolytic cleavage of the membrane-bound precursor and can function as an agonistic molecule that can actively participate in cell-to-cell signaling. The second subunit of the IL-6 complex, gp130, also functions as a component of several additional receptor complexes including leukemia inhibitory factor (LIF), oncostatin M (OSM), ciliary neurotrophic factor (CNTF) and IL-11. LIF binds to the LIF receptor with low affinity and to a complex of the LIF receptor and gp130 with high affinity while OSM appears to bind to gp130 with low affinity and to a complex of gp130 and the LIF receptor with high affinity.